4Voland C,Serre CM,Delmzs P.Platelet-osteosarcoma cell interaction is mediated through a specific fibrinogen-binding sequence located within the N-terminal domain of thrombospondin 1[J].J Boneminer Res,2000,15(2):361-368.
5Gouin-Thibaalt 1,Samama MM.Laboratory diagnosis of the thrombophilic state in cancer patients[J].Semin Thromb Hemost.1999,25(2):167-172.
6Lopez Y,Paloma MJ,Rifor J,et al.Measurement of prefllrombotic markers in the assessment of acquired hypercoagulable states[J].Thromb Res,1999,93(2):71-78.
7Nakata S,Ito K,Fujimori M,et al.Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers[J].Int J Cancer,1998,79(2):179-185.
8Wada H,Salkuragawa N,Mori Y,et al.Hemostatic molecular markers before the onset of disseminated intravascular coagulation[J].Am J Hematol,1999,60(4):273-278.
9Ozturk M,Sengul N,Dagli M,et al.Global fibrinolytic capacity incolorectal cancer:,a new clue to occult flbrinolysis[J].Clin Appl Thromb Hemost,2003,9(2):151-154.
10Becker BF,Heindl B,Kupatt C,et al.Endothelial function and hemostasis[J].Z Kardiol,2000,89(3):160-167.
